AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Hourly Market Review - Aug 2, 2024 12 PM
Generated by AI AgentAinvest Market Brief
Friday, Aug 2, 2024 1:00 pm ET1min read
BFLY--
BIO.B--
CERS--
IAS--
TNDM--
Movers of the hour:
Tandem Diabetes Care is up 20.53% at $42.44.
Butterfly Network is up 17.82% at $1.19.
Bio-Rad Laboratories B is up 15.39% at $339.51.
Integral Ad Science is up 14.93% at $11.40.
Cerus is up 14.21% at $2.33.
Here are the top stocks upgraded by Wall Street analyst:
Apple has received a rating of Strong Buy from B of A Securities with target price increased to $230 from $230.
Apple has received a rating of Strong Buy from Needham with target price increased to $260 from $220.
Apple has received a rating of Buy from Wedbush with target price increased to $275 from $275.
Apple has received a rating of Strong Buy from Loop Capital with target price increased to $300 from $170.
Apple has received a rating of Strong Buy from CFRA with target price increased to $260 from $240.
Apple has received a rating of Strong Buy from Goldman Sachs with target price increased to $265 from $238.
Apple has received a rating of Sell from Barclays with target price increased to $187 from $164.
Apple has received a rating of Buy from Baird with target price increased to $240 from $200.
Apple has received a rating of Buy from Raymond James with target price increased to $250 from $200.
Apple has received a rating of Strong Buy from TD Cowen with target price increased to $250 from $220.
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc's editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet